BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30877678)

  • 1. Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
    González E; Reyes F; Otero O; Camacho F; Cuello M; Ramírez F; Acevedo R
    Methods Mol Biol; 2019; 1969():181-203. PubMed ID: 30877678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
    Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
    J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
    Lucidarme J; Louth J; Townsend-Payne K; Borrow R
    Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
    Pon RA; Lussier M; Yang QL; Jennings HJ
    J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow Cytometric Assays to Quantify fHbp Expression and Detect Serotype Specific Capsular Polysaccharides on Neisseria meningitidis.
    Loschko J; Garcia K; Cooper D; Pride M; Anderson A
    Methods Mol Biol; 2019; 1969():217-236. PubMed ID: 30877680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to four Neisseria meningitidis serogroups.
    Martins TB; Jaskowski TD; Tebo A; Hill HR
    J Immunol Methods; 2009 Mar; 342(1-2):98-105. PubMed ID: 19159627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.
    Pichichero M; Casey J; Blatter M; Rothstein E; Ryall R; Bybel M; Gilmet G; Papa T
    Pediatr Infect Dis J; 2005 Jan; 24(1):57-62. PubMed ID: 15665711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives for development of polyvalent meningococcal vaccine].
    Basnak'ian IA; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (7):54-8. PubMed ID: 17297881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
    Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
    Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.